{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:42:58Z","timestamp":1790541778510,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.clnu.2020.11.005","type":"journal-article","created":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T02:08:26Z","timestamp":1604714906000},"page":"3325-3331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["The effect of vitamin D supplementation on the progression of benign prostatic hyperplasia: A randomized controlled trial"],"prefix":"10.1016","volume":"40","author":[{"given":"Abolfazl","family":"Zendehdel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnaz","family":"Khatami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shapour","family":"Mansoursamaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Dialameh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2020.11.005_bib1","series-title":"Prostate enlargement: benign prostatic hyperplasia: national institute of diabetes and digestive and kidney diseases","year":"1998"},{"key":"10.1016\/j.clnu.2020.11.005_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.clnesp.2019.07.015","article-title":"Benign prostate hyperplasia and nutrition","volume":"33","author":"Das","year":"2019","journal-title":"Clinical nutrition ESPEN"},{"issue":"4","key":"10.1016\/j.clnu.2020.11.005_bib3","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.urology.2007.06.1099","article-title":"Onion and garlic intake and the odds of benign prostatic hyperplasia","volume":"70","author":"Galeone","year":"2007","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.clnu.2020.11.005_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/MOU.0b013e32835abd05","article-title":"Nutrition and benign prostatic hyperplasia","volume":"23","author":"Espinosa","year":"2013","journal-title":"Curr Opin Urol"},{"issue":"4","key":"10.1016\/j.clnu.2020.11.005_bib5","first-page":"689","article-title":"Intakes of energy and macronutrients and the risk of benign prostatic hyperplasia","volume":"75","author":"Suzuki","year":"2002","journal-title":"AJCN (Am J Clin Nutr)"},{"issue":"7","key":"10.1016\/j.clnu.2020.11.005_bib6","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0046-8177(96)90396-2","article-title":"Apoptotic versus proliferative activities in human benign prostatic hyperplasia","volume":"27","author":"Kyprianou","year":"1996","journal-title":"Hum Pathol"},{"issue":"12","key":"10.1016\/j.clnu.2020.11.005_bib7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11934-014-0463-9","article-title":"The role of inflammation in lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) and its potential impact on medical therapy","volume":"15","author":"Ficarra","year":"2014","journal-title":"Curr Urol Rep"},{"issue":"4","key":"10.1016\/j.clnu.2020.11.005_bib8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/pros.10020","article-title":"Differential expression of interleukin-15, a pro-inflammatory cytokine and T-cell growth factor, and its receptor in human prostate","volume":"49","author":"Handisurya","year":"2001","journal-title":"Prostate"},{"issue":"8","key":"10.1016\/j.clnu.2020.11.005_bib9","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/01.LAB.0000081388.40145.65","article-title":"Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue","volume":"83","author":"Steiner","year":"2003","journal-title":"Lab Invest"},{"issue":"1","key":"10.1016\/j.clnu.2020.11.005_bib10","first-page":"119","article-title":"Interferon-g and its functional receptors overexpression in benign prostatic hyperplasia and prostatic carcinoma: parallelism with c-myc and p53 expression","volume":"11","author":"Royuela","year":"2000","journal-title":"Eur Cytokine Netw"},{"issue":"3","key":"10.1016\/j.clnu.2020.11.005_bib11","first-page":"805","article-title":"Antiproliferative effects of 1, 25-dihydroxyvitamin D3 on primary cultures of human prostatic cells","volume":"54","author":"Peehl","year":"1994","journal-title":"Canc Res"},{"issue":"5","key":"10.1016\/j.clnu.2020.11.005_bib12","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1210\/endo.132.5.7682937","article-title":"Vitamin D and prostate cancer: 1, 25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines","volume":"132","author":"Skowronski","year":"1993","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.clnu.2020.11.005_bib13","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1464-410X.2012.11559.x","article-title":"Non-steroidal anti-inflammatory drugs for lower urinary tract symptoms in benign prostatic hyperplasia: systematic review and meta-analysis of randomized controlled trials","volume":"111","author":"Kahokehr","year":"2013","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.clnu.2020.11.005_bib14","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1749-6632.2009.05299.x","article-title":"Vitamin D receptor agonists target static, dynamic, and inflammatory components of benign prostatic hyperplasia","volume":"1193","author":"Adorini","year":"2010","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.clnu.2020.11.005_bib15","first-page":"320","article-title":"Vitamin D analogs as therapeutic agents: a clinical study update","volume":"5","author":"Wu-Wong","year":"2004","journal-title":"Curr Opin Invest Drugs"},{"issue":"6","key":"10.1016\/j.clnu.2020.11.005_bib16","first-page":"1689S","article-title":"Overview of general physiologic features and functions of vitamin D","volume":"80","author":"DeLuca","year":"2004","journal-title":"AJCN (Am J Clin Nutr)"},{"issue":"4","key":"10.1016\/j.clnu.2020.11.005_bib17","first-page":"6820","article-title":"Vitamin D and benign prostatic hyperplasia--a review","volume":"20","author":"Espinosa","year":"2013","journal-title":"Can J Urol"},{"issue":"9","key":"10.1016\/j.clnu.2020.11.005_bib18","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1517\/13543784.16.9.1425","article-title":"Advances in the development of hormonal modulators for the treatment of benign prostatic hyperplasia","volume":"16","author":"Tiwari","year":"2007","journal-title":"Expet Opin Invest Drugs"},{"issue":"12","key":"10.1016\/j.clnu.2020.11.005_bib19","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1002\/1097-0142(19921215)70:12<2861::AID-CNCR2820701224>3.0.CO;2-G","article-title":"Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation","volume":"70","author":"Hanchette","year":"1992","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.clnu.2020.11.005_bib20","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00432-014-1706-3","article-title":"Positive association between circulating 25-hydroxyvitamin D levels and prostate cancer risk: new findings from an updated meta-analysis","volume":"140","author":"Xu","year":"2014","journal-title":"J\u00a0Canc Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.clnu.2020.11.005_bib21","first-page":"173","article-title":"Calcium and phosphorus intake and prostate cancer risk: a 24-y follow-up study","volume":"101","author":"Wilson","year":"2015","journal-title":"AJCN (Am J Clin Nutr)"},{"key":"10.1016\/j.clnu.2020.11.005_bib22","series-title":"Vitamin D in health and disease: vitamin D and the epidemiology of prostate cancer. Seminars in dialysis","year":"2005"},{"issue":"1","key":"10.1016\/j.clnu.2020.11.005_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/pcan.2016.41","article-title":"Does prostate volume correlate with vitamin D deficiency among men undergoing prostate biopsy?","volume":"20","author":"Murphy","year":"2017","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"10.1016\/j.clnu.2020.11.005_bib24","first-page":"608","article-title":"Low 25-OH vitamin D is associated with benign prostatic hyperplasia","volume":"190","author":"Haghsheno","year":"2013","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clnu.2020.11.005_bib25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.urology.2016.03.070","article-title":"Vitamin D deficiency as a potential marker of benign prostatic hyperplasia","volume":"97","author":"Zhang","year":"2016","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.clnu.2020.11.005_bib26","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2005.08.014","article-title":"BXL628, a novel vitamin D3 analog arrests prostate growth in patients with benign prostatic hyperplasia: a randomized clinical trial","volume":"49","author":"Colli","year":"2006","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.clnu.2020.11.005_bib27","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/andr.12092","article-title":"Hypovitaminosis D is associated with lower urinary tract symptoms and benign prostate hyperplasia in type 2 diabetes","volume":"3","author":"Caretta","year":"2015","journal-title":"Andrology"},{"issue":"4","key":"10.1016\/j.clnu.2020.11.005_bib28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5539\/gjhs.v7n4p243","article-title":"Effects of vitamin D intake on FEV1 and COPD exacerbation: a randomized clinical trial study","volume":"7","author":"Zendedel","year":"2015","journal-title":"Global J Health Sci"},{"key":"10.1016\/j.clnu.2020.11.005_bib29","article-title":"Vitamin and trace mineral deficiency and excess","volume":"1","author":"Russell","year":"2005","journal-title":"Harrison\u2019s Princ Int Med"},{"issue":"4","key":"10.1016\/j.clnu.2020.11.005_bib30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/13685538.2017.1362380","article-title":"Use of the international prostate symptom score (IPSS) in Chinese male patients with benign prostatic hyperplasia","volume":"20","author":"Wong","year":"2017","journal-title":"Aging Male"},{"issue":"7","key":"10.1016\/j.clnu.2020.11.005_bib31","first-page":"2576","article-title":"Effect of a vitamin D3 analogue on keratinocyte growth factor-induced cell proliferation in benign prostate hyperplasia","volume":"85","author":"Crescioli","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"issue":"3","key":"10.1016\/j.clnu.2020.11.005_bib32","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/pros.20463","article-title":"BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA\/Rho kinase signaling in rat and human bladder","volume":"67","author":"Morelli","year":"2007","journal-title":"Prostate"},{"issue":"1\u20132","key":"10.1016\/j.clnu.2020.11.005_bib33","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jsbmb.2010.03.043","article-title":"A\u00a0novel nonsecosteroidal VDR agonist (CH5036249) exhibits efficacy in a spontaneous benign prostatic hyperplasia beagle model","volume":"121","author":"Taniguchi","year":"2010","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"issue":"7","key":"10.1016\/j.clnu.2020.11.005_bib34","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s00345-018-2536-8","article-title":"Cholecalciferol for the prophylaxis against recurrent urinary tract infection among patients with benign prostatic hyperplasia: a randomized, comparative study","volume":"37","author":"Safwat","year":"2019","journal-title":"World J Urol"},{"issue":"8","key":"10.1016\/j.clnu.2020.11.005_bib35","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/aje\/kwm389","article-title":"Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial","volume":"167","author":"Kristal","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.clnu.2020.11.005_bib36","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/pros.20896","article-title":"The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA\/Rho kinase and NF-kB pathways","volume":"69","author":"Penna","year":"2009","journal-title":"Prostate"},{"issue":"9","key":"10.1016\/j.clnu.2020.11.005_bib37","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ejcn.2016.20","article-title":"Vitamin D and incident urinary incontinence in older adults","volume":"70","author":"Vaughan","year":"2016","journal-title":"Eur J Clin Nutr"},{"issue":"1","key":"10.1016\/j.clnu.2020.11.005_bib38","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s40064-016-2009-8","article-title":"Association of vitamin D receptor variants with clinical parameters in prostate cancer","volume":"5","author":"Nunes","year":"2016","journal-title":"SpringerPlus"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561420306099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561420306099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T01:10:10Z","timestamp":1759367410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561420306099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0261561420306099"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2020.11.005","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of vitamin D supplementation on the progression of benign prostatic hyperplasia: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2020.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}